Effect of fructooligosaccharide on endothelial function in CKD patients: a randomized controlled trial

被引:16
|
作者
Armani, Rachel G. [1 ]
Carvalho, Aluizio B. [1 ]
Ramos, Christiane, I [1 ]
Hong, Valeria [2 ]
Bortolotto, Luiz A. [2 ]
Cassiolato, Jose Luiz [3 ]
Oliveira, Natacha F. [4 ]
Cieslarova, Zuzana [5 ]
do Lago, Claudimir L. [5 ]
Klassen, Aline [4 ]
Cuppari, Lilian [1 ]
Raj, Dominic S. [6 ]
Canziani, Maria Eugenia F. [1 ]
机构
[1] Univ Fed Sao Paulo, Div Nephrol, Dept Med, Sao Paulo, Brazil
[2] Univ Sao Paulo, Heart Inst, Sao Paulo, Brazil
[3] CARDIOS, Adv Cardiol Equipment, Sao Paulo, Brazil
[4] Univ Fed Sao Paulo, Dept Chem, Diadema, Brazil
[5] Univ Sao Paulo, Inst Chem, Sao Paulo, Brazil
[6] George Washington Univ, Div Kidney Dis & Hypertens, Washington, DC USA
基金
巴西圣保罗研究基金会;
关键词
chronic kidney disease; endothelial dysfunction; flow-mediated dilatation; fructooligosaccharide; gut microbiota; CHRONIC KIDNEY-DISEASE; BOUND UREMIC TOXINS; OXIDATIVE STRESS; INDOXYL SULFATE; BRACHIAL-ARTERY; GUT MICROBIOME; PREBIOTICS; ATHEROSCLEROSIS; INTERLEUKIN-6; VASODILATION;
D O I
10.1093/ndt/gfaa335
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Microbiota-derived uremic toxins have been associated with inflammation that could corroborate with endothelial dysfunction (ED) and increase cardiovascular risk in patients with chronic kidney disease (CKD). This trial aimed to evaluate the effect of the prebiotic fructooligosaccharide (FOS) on endothelial function and arterial stiffness in nondialysis CKD patients. Methods. In a double-blind controlled trial, 46 nondiabetic CKD patients were randomized to receive 12 g/day of FOS or placebo (maltodextrin) for 3 months. Total p-cresyl sulfate (PCS) and indoxyl sulfate by high-performance liquid chromatography, urinary trimethylamine N-oxide by mass spectrometry, C-reactive protein, interleukin-6 (IL-6), serum nitric oxide and stroma-derived factor-1 alfa were measured at baseline and at the end of follow-up; endothelial function was assessed through flow-mediated dilatation (FMD) and arterial stiffness by pulse wave velocity (PWV). Results. The mean (+/- standard deviation) age of the study participants was 57.6 +/- 14.4 years, with an estimated glomerular filtration rate of 21.3 +/- 7.3 mL/min/1.73 m(2). During the follow-up, regarding the inflammatory markers and uremic toxins, there was a significant decrease in IL-6 levels (3.4 +/- 2.1 pg/mL versus 2.6 +/- 1.4 pg/mL; P = 0.04) and a trend toward PCS reduction (55.4 +/- 38.1 mg/L versus 43.1 +/- 32.4 mg/L, P = 0.07) only in the prebiotic group. Comparing both groups, there was no difference in FMD and PWV. In an exploratory analysis, including a less severe ED group of patients (FMD >= 2.2% at baseline), FMD remained stable in the prebiotic group, while it decreased in the placebo group (group effect P = 0.135; time effect P = 0.012; interaction P = 0.002). Conclusions. The prebiotic FOS lowered circulating levels of IL-6 in CKD patients and preserved endothelial function only in those with less damaged endothelium. No effect of FOS in arterial stiffness was observed.
引用
收藏
页码:85 / 91
页数:7
相关论文
共 50 条
  • [41] Mediterranean diet and endothelial function in patients with coronary heart disease: An analysis of the CORDIOPREV randomized controlled trial
    Yubero-Serrano, Elena M.
    Fernandez-Gandara, Carolina
    Garcia-Rios, Antonio
    Rangel-Zuniga, Oriol A.
    Gutierrez-Mariscal, Francisco M.
    Torres-Pena, Jose D.
    Marin, Carmen
    Lopez-Moreno, Javier
    Castano, Justo P.
    Delgado-Lista, Javier
    Ordovas, Jose M.
    Perez-Martinez, Pablo
    Lopez-Miranda, Jose
    PLOS MEDICINE, 2020, 17 (09)
  • [42] Effects of rivaroxaban on vascular endothelial function and circulating endothelial progenitor cells: a randomized controlled trial
    Lin, M.
    Wong, C. K.
    Chan, K. Y.
    Tsui, F.
    Au, K. W.
    Choo, A.
    Tam, C. C.
    Tse, H. F.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [43] Effects of rivaroxaban on vascular endothelial function and circulating endothelial progenitor cells: a randomized controlled trial
    Lin, M.
    Wong, C. K.
    Chan, K. Y.
    Tsui, F.
    Au, K. W.
    Choo, A.
    Tam, C. C.
    Tse, H. F.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [44] A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial
    Cooney, Danielle
    Moon, Helen
    Liu, Yang
    Miller, Richard Tyler
    Perzynski, Adam
    Watts, Brook
    Drawz, Paul E.
    BMC NEPHROLOGY, 2015, 16
  • [45] Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD
    Bushinsky, David A.
    Hostetter, Thomas
    Klaerner, Gerrit
    Stasiv, Yuri
    Lockey, Claire
    McNulty, Sarah
    Lee, Angela
    Parsell, Dawn
    Mathur, Vandana
    Li, Elizabeth
    Buysse, Jerry
    Alpern, Robert
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (01): : 26 - 35
  • [46] Effect of Treatment of Metabolic Acidosis on Vascular Endothelial Function in Patients with CKD A Pilot Randomized Cross-Over Study
    Kendrick, Jessica
    Shah, Pratik
    Andrews, Emily
    You, Zhiying
    Nowak, Kristen
    Pasch, Andreas
    Chonchol, Michel
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (10): : 1463 - 1470
  • [47] Sodium Restriction in Patients With CKD: A Randomized Controlled Trial of Self-management Support
    Meuleman, Yvette
    Hoekstra, Tiny
    Dekker, Friedo W.
    Navis, Gerjan
    Vogt, Liffert
    van der Boog, Paul J. M.
    Bos, Willem Jan W.
    van Montfrans, Gert A.
    van Dijk, Sandra
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 69 (05) : 576 - 586
  • [48] A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial
    Danielle Cooney
    Helen Moon
    Yang Liu
    Richard Tyler Miller
    Adam Perzynski
    Brook Watts
    Paul E Drawz
    BMC Nephrology, 16
  • [49] The Effect of Linagliptin on the Endothelial Function and Arginine Bioavailability Ratio in CHD Patients with Early Type 2 Diabetes Mellitus - A Randomized Controlled Trial
    Aberer, Felix
    Tripolt, Norbert
    Riedl, Regina
    Hutz, Barbara
    Url, Jasmin
    Brodmann, Marianne
    Meinitzer, Andreas
    Stojakovic, Tatjana
    Dimsity, Gudrun
    Hoedl, Ronald
    Hafner, Franz
    Sourij, Harald
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : 162 - 162
  • [50] Periodontal therapy and endothelial function in coronary artery disease: A randomized controlled trial
    Saffi, Marco Aurelio L.
    Rabelo-Silva, Eneida R.
    Polanczyk, Carisi A.
    Furtado, Mariana V.
    Montenegro, Marlon M.
    Ribeiro, Ingrid W. J.
    Kampits, Cassio
    Rosing, Cassiano K.
    Haas, Alex N.
    ORAL DISEASES, 2018, 24 (07) : 1349 - 1357